When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

TJ Bio has reportedly submitted a biologics license application (BLA) to China’s Center for Drug Evaluation for GX-H9 ...

Ziltivekimab is under clinical development by Novo Nordisk and currently in Phase III for Myocardial Infarction.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

However, major pharmaceutical companies face a $300 billion growth gap due to patent ... rare blood and endocrine disorders, and hormone replacement therapy. Novo Nordisk A/S (NYSE:NVO) ranks ...

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...

The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, ...

INR:8593. help mpl com Novo Nordisk's once-weekly long-acting growth hormone has been approved for clinical trials in China These 15 innovative drugs that will recei ...

Subcutaneous injection of growth hormone once a week! Novo Nordisk's Sogroya is recommended by the EU CHMP The risk of ...

Diabetes drugs now represent over 75% of total sales in the metabolic disorders market, up from below 40% ten years ago. The ...